About Envisagenics
RNA Therapeutics Development
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
New York, United States
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
envisagenics.com
Domain Registered Date
Mar 28, 2013
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $25,000,000 · Series-B+
startupintros.com
- Capital Raise
Raised $19,000,000 · Series-A
startupintros.com
- Capital Raise
Raised $1,000,000 · Seed
startupintros.com
- Milestone
X account created (@envisagenics)
1.1K followers
- Milestone
Website domain registered
envisagenics.com
Investors & Backers
Bristol-Myers Squibb
Empire State Development
M12
Madrona
National Cancer Institute
New York Ventures
Red Cell Partners
Third Kind Venture Capital
Funding History
Series-B+
· Jun 5, 2024
$25,000,000 startupintros.com
Series-A
· Sep 1, 2021
$19,000,000 startupintros.com
Seed
· Apr 1, 2018
$1,000,000 startupintros.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026